MedTrace Logo

Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)

NCT05784038 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-07-17

No results posted yet for this study

Summary

The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.

Conditions

Interventions

DIAGNOSTIC_TEST

Viral genomic

Evaluation of mpox viral genomic

DIAGNOSTIC_TEST

Untargeted Metabolomics

Evaluation of metabolomics of the total plasma, oropharynx, and skin samples.

Sponsors & Collaborators

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Henrique Fonseca · Hospital Albert Einstein

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-16
Primary Completion
2025-01-31
Completion
2026-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784038 on ClinicalTrials.gov